acquired
Stage
About
S-Biomedic develops living skin probiotics derived from Cutibacterium to modulate the skin microbiome and address skin conditions such as acne, eczema, rosacea and skin aging. The company provides microbiome-based active ingredients and collaborates with consumer skincare companies.
Explore S-Biomedic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.